David C. Morrison - Concepedia

Author

David C. Morrison

Also Known As

D C Morrison, D. C. Morrison, D. C. Morrison;, D.C. MORRISON, D.C. Morrison, DAVID C. MORRISON, David C Morrison, David C. MORRISON, David C. Morrison, David. C. Morrison

276

Publications

13.3K

Citations

H-Index

139

Concepts

All Affiliations

University of Kansas Medical Center University of Missouri–Kansas City Scripps Health Scripps Clinic Emory University

About

David C. Morrison is an author at University of Kansas Medical Center specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	92	5.6K
2	Natural Sciences	12	13	508
3	Health Sciences	7	7	182
4	Engineering	3	3	121
5	Public Health	1	1	79

David C. Morrison

149

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides David C. Morrison, Diane M. Jacobs Immunochemistry Proteinlipid InteractionBiosynthesisBiochemistryVirulence FactorBacterial Lipopolysaccharides	1976	825
The effects of bacterial endotoxins on host mediation systems. A review. David C. Morrison, Richard J. Ulevitch PubMed Host ResponseMicrobial ToxinToxinologyMicrobial PathogensMedicine	1978	642
Activation of the Classical and Properdin Pathways of Complement by Bacterial Lipopolysaccharides (LPS) David C. Morrison, Lois Kline The Journal of Immunology Complement SystemClassical Pathway ActivationSignal TransductionBiochemistryVirulence Factor	1977	443
An Interferon-γ-activated Site (GAS) Is Necessary for Full Expression of the Mouse iNOS Gene in Response to Interferon-γ and Lipopolysaccharide Jianjun Gao, David C. Morrison, Tari Parmely, Journal of Biological Chemistry	1997	299
DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS) David C. Morrison, Charles G. Cochrane The Journal of Experimental Medicine InflammationMicrobial ToxinProteinlipid InteractionBiochemistrySoluble Bacterial Lipopolysaccharide	1974	261
Immunologic Properties of Bacterial Lipopolysaccharide (LPS): Correlation between the Mitogenic, Adjuvant, and Immunogenic Activities Barry J. Skidmore, Jacques M. Chiller, David C. Morrison, The Journal of Immunology	1975	238
Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-<i>alpha</i> production and protect mice against endotoxin challenge. Michael J. Parmely, Wei Zhou, Carl K. Edwards, The Journal of Immunology	1993	192
Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. X Zhang, David C. Morrison The Journal of Experimental Medicine Lung InflammationNitric OxideImmunologyCell DeathOxidative Stress	1993	174
Relationship of the Structure of Bacterial Lipopolysaccharides to Its Function in Mitogenesis and Adjuvanticity Jacques M. Chiller, Barry J. Skidmore, David C. Morrison, Proceedings of the National Academy of Sciences Humoral ResponseBacteriologyImmunologyAntigen ProcessingImmune System	1973	172
Stimulation of a T-Independent Primary Anti-Hapten Response in Vitro by TNP-Lipopolysaccharide (TNP-LPS) Diane M. Jacobs, David C. Morrison The Journal of Immunology InflammationCytokineCore PolysaccharideNeuropeptidesSignal Transduction	1975	168

Page 1